A Safety and Effectiveness Study of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation

NACompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

June 28, 2016

Primary Completion Date

February 6, 2018

Study Completion Date

October 11, 2018

Conditions
Chin Retrusion
Interventions
DEVICE

JUVÉDERM VOLUMA® XC

JUVÉDERM VOLUMA® XC was injected into the chin at a volume determined by the investigator. The maximum total volume administered was up to 4 mL.

Trial Locations (14)

10549

The Center for Dermatology, Cosmetics, & Laser Surgery, Mount Kisco

12110

Williams Plastic Surgery Specialists, Latham

20769

Callender Dermatology and Cosmetic Center, Glenn Dale

29414

Dermatology & Laser Center of Charleston Center for Clinical Research, Charleston

33137

Baumann Cosmetic and Res. Institute, Miami Beach

33146

Skin Research Institute, Coral Gables

33401

Research Institute of the Southeast, West Palm Beach

37203

Nashville Centre for Laser and Facial Surgery, Nashville

60611

DeNova Research, Chicago

63104

St Louis University Medical Center Dept. of Dermatology, St Louis

92121

Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc., San Diego

99202

Premier Clinical Research; Spokane Dermatology Clinic, Spokane

01467

SkinCare Physicians of Chestnut Hill, Chestnut Hill

07042

Image Dermatology, PC, Montclair

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY